Whitecar JP, Bodey GP, Harris JE et al: L-Asparaginase. N Engl J Med282:732-734, 1970
3.
Capizzi RL, Holcenberg JS: Asparaginase, in Holland JF, Frei E III, Bast RC Jr , et al (eds): Cancer Medicine (ed 2). Philadelphia, PA, Lea & Febiger , 1993
4.
Capizzi RL, Bertino JR, Skeel RT, et al: L-asparaginase. Ann Intern Med74:893-901, 1971
5.
Riccardi R., Holcenberg JS, Glaubiger DL, et al: L-asparaginase pharmacokinetics and asparagine levels in cerebrospinal fluid of Rhesus monkeys and humans. Cancer Res41:4554-4558, 1981
6.
Chabner BA: Enzyme therapy: L-asparaginase, in Chabner BA, Collins JM (eds): Cancer Chemotherapy: Principles & Practice. Philadelphia, PA, Lipincott, 1990
7.
Ohnuma T., Holland JF, Meyer P.: Erwinia carotovora asparaginase in patients with prior anaphylaxis to asparaginase from E coli. Cancer30:376-381, 1970
8.
Kurtzberg J., Asselin B., Graham ML, et al: L-asparaginase therapy in the 90s: New insights into pharmacology should guide future therapeutic applications. Proc Am Soc Ped Heine/Onc, Chicago, IL, October 1993 (abstr)
9.
Abuchowski A. , Kazo G., Verhoest C., et al: Cancer therapy with chemically modified enzymes. I. Antitumor properties of polyethylene gluco-asparaginase conjugates . Cancer Biochem Biophys7:175-186, 1984
10.
Ettinger LJ , Asselin B., Poplack DG, et al: Toxicity profile of PEG-L-asparaginase in native L-asparaginase-hypersensitive and non-hypersensitive patients (pts) with acute lymphoblastic leukemia (ALL). Med Pediatr Oncol21: 556, 1993 (abstr)
